Betapace Af
NDC Package 50419-119-06
Package Information
Betapace Af is a medication used to treat a serious (possibly life-threatening) type of fast heartbeat called sustained ventricular tachycardia. Marketed by Bayer Healthcare Pharmaceuticals Inc., this product is identified by NDC 50419-119 and is authorized under FDA application NDA021151.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50419 - Bayer Healthcare Pharmaceuticals Inc.
- 50419-119 - Betapace Af
- 50419-119-06 - 1 BOTTLE, PLASTIC in 1 PACKAGE / 60 TABLET in 1 BOTTLE, PLASTIC
- 50419-119 - Betapace Af
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50419-119-06 identifies a specific commercial package of 1 bottle, plastic in 1 package / 60 tablet in 1 bottle, plastic of Betapace Af, labeled by Bayer Healthcare Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bayer Healthcare Pharmaceuticals Inc. on February 22, 2000. The current certification is valid through November 10, 2017.
What are the primary indications for this medication?
This medication is used to treat a serious (possibly life-threatening) type of fast heartbeat called sustained ventricular tachycardia. It is also used to treat certain fast/irregular heartbeats (atrial fibrillation/flutter) in patients with severe symptoms such as weakness and shortness of breath. Sotalol helps to lessen these symptoms. It slows the heart rate and helps the heart to beat more normally and regularly. This medication is both a beta blocker and an anti-arrhythmic.
How is this Bayer Healthcare Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50419011906. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.